Estate Counselors LLC Buys New Position in Astera Labs, Inc. $ALAB

Estate Counselors LLC purchased a new position in Astera Labs, Inc. (NASDAQ:ALAB) during the 3rd quarter, according to its most recent disclosure with the SEC. The fund purchased 20,619 shares of the company’s stock, valued at approximately $4,037,000.

A number of other large investors also recently modified their holdings of ALAB. Sumitomo Mitsui Trust Group Inc. grew its position in Astera Labs by 21.6% in the 2nd quarter. Sumitomo Mitsui Trust Group Inc. now owns 14,781 shares of the company’s stock worth $1,336,000 after purchasing an additional 2,624 shares during the last quarter. Maryland State Retirement & Pension System lifted its stake in shares of Astera Labs by 37.7% in the second quarter. Maryland State Retirement & Pension System now owns 6,960 shares of the company’s stock valued at $629,000 after buying an additional 1,906 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. grew its position in Astera Labs by 94.6% during the second quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 109,576 shares of the company’s stock worth $9,908,000 after buying an additional 53,276 shares in the last quarter. Realta Investment Advisors acquired a new stake in Astera Labs during the second quarter worth about $214,000. Finally, Vanguard Personalized Indexing Management LLC increased its stake in Astera Labs by 142.4% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 11,366 shares of the company’s stock valued at $1,028,000 after acquiring an additional 6,677 shares during the period. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Astera Labs

In other news, Director Manuel Alba sold 150,000 shares of the stock in a transaction on Monday, December 1st. The stock was sold at an average price of $166.18, for a total transaction of $24,927,000.00. Following the sale, the director owned 1,574,498 shares in the company, valued at approximately $261,650,077.64. This represents a 8.70% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Michael Truett Tate sold 11,430 shares of the firm’s stock in a transaction on Monday, November 17th. The shares were sold at an average price of $144.69, for a total value of $1,653,806.70. Following the completion of the sale, the chief financial officer owned 192,297 shares of the company’s stock, valued at approximately $27,823,452.93. This trade represents a 5.61% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 576,936 shares of company stock worth $87,409,540 over the last 90 days. Company insiders own 12.50% of the company’s stock.

Astera Labs Stock Performance

ALAB opened at $169.66 on Monday. The firm has a market cap of $28.66 billion, a price-to-earnings ratio of 152.85, a PEG ratio of 2.31 and a beta of 1.50. The firm’s 50-day simple moving average is $161.80 and its 200-day simple moving average is $169.83. Astera Labs, Inc. has a twelve month low of $47.13 and a twelve month high of $262.90.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.10. The firm had revenue of $230.58 million during the quarter, compared to the consensus estimate of $206.42 million. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. The firm’s quarterly revenue was up 103.9% on a year-over-year basis. During the same period last year, the firm posted $0.23 EPS. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. As a group, sell-side analysts anticipate that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

ALAB has been the subject of a number of research reports. Jefferies Financial Group reiterated a “buy” rating on shares of Astera Labs in a research report on Wednesday, December 3rd. Zacks Research lowered Astera Labs from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 6th. Northland Securities lifted their price target on shares of Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 9th. Weiss Ratings reissued a “hold (c-)” rating on shares of Astera Labs in a report on Wednesday. Finally, Royal Bank Of Canada began coverage on shares of Astera Labs in a report on Wednesday, January 14th. They set an “outperform” rating and a $225.00 price objective for the company. Fifteen research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat, Astera Labs currently has an average rating of “Moderate Buy” and an average price target of $190.63.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.